Joined in 2023 
82 
63 About this deal
Chanmee T, Ontong P, Konno K, Itano N (2014) Tumor-associated macrophages as major players in the tumor microenvironment. Cancers 6:1670–1690. https://doi.org/10.3390/cancers6031670
Patients were defined as evaluable for PopPK analysis if they had at least one adequately documented tislelizumab administration and a corresponding PK sample collection after the dose. Tislelizumab serum concentrations in the samples were quantified using validated bioanalytical assays using an enzyme‐linked immunosorbent assay method. The lower limit of quantification for tislelizumab was 400ng/ml. The antidrug antibody (ADA) binding assay employed the electrochemiluminescence immunoassay method to detect the presence of anti‐tislelizumab antibodies in human serum. Bruhns P (2012) Properties of mouse and human IgG receptors and their contribution to disease models. Blood 119:5640–5649. https://doi.org/10.1182/blood-2012-01-380121 HuT78/P3Z cells were pre-incubated with BGB-A317 (0.0014-3 µg/mL) for 15 min prior to co-culturing with HEK293/PD-L1 cells in 96-well plates (Costar) containing complete RPMI1640 media. The cells were incubated for 17 h at 37 °C. IL-2 secretion in the supernatants of co-culture was assayed by ELISA using a kit from eBioscience, according to manufacturer’s instructions. Human PBMC separationDavies AM, Sutton BJ (2015) Human IgG4: a structural perspective. Immunol Rev 268:139–159. https://doi.org/10.1111/imr.12349 A study investigating safety, tolerability, PK, and preliminary antitumor activities of anti–PD‐1 monoclonal antibody tislelizumab (BGB‐A317) in Chinese patients with advanced solid tumors The analysis shows that tislelizumab PKis linear across the dose range tested. Tislelizumab exposures are similar across various covariates, including body weight and tumor type, and clinical factors such as hepatic and renal status have no significant effect on tislelizumab PK. These results support the use of tislelizumab 200mg intravenously every 3weeks without dose adjustment in a variety of patient subpopulations. Lopez AF, Strath M, Sanderson CJ (1984) Differentiation antigens on mouse eosinophils and neutrophils identified by monoclonal antibodies. Br J Haematol 57:489–494
Swann JB, Smyth MJ (2007) Immune surveillance of tumors. J Clin Investig 117:1137–1146. https://doi.org/10.1172/JCI31405 Unsurprisingly, it really struggles in our benchmarks. Watching it labour through Cinebench R20 and record a result that represents about one sixth of the performance registered by something like a low-end Intel Core i5 quad-core mobile processor is pretty painful, even if it does serve as a timely reminder that mainstream laptops will full featured if more affordable CPUs like the Core i5 now offer remarkable performance. A summary of covariate effects (evaluated for the 10 th and 90 th percentiles of covariate distributions) on tislelizumab PK parameters (CL and V c) are presented in Table S3. The steady‐state volume of distribution was 6.42L, and the geometric mean elimination half‐life was 23.8days with a CV of 31%. The time to reach 90% steady‐state level was approximately 84days (12 weeks). In this test we use 100% on the CPU cores, monitoring their frequencies and chip temperature. The first column shows a computer’s reaction to a short load (2-10 seconds), the second column simulates a serious task (between 15 and 30 seconds), and the third column is a good indicator of how good the laptop is for long loads such as video rendering. Aspire 3 - Pentium Silver N5000 / 1.1 GHz / 8 GB DDR4 / Intel UHD Graphics 605 / 256 GB SSD / 17.3" - IPSZhang QW, Liu L, Gong CY, Shi HS, Zeng YH, Wang XZ, Zhao YW, Wei YQ (2012) Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature. PloS One 7:e50946. https://doi.org/10.1371/journal.pone.0050946 In the illustration below you can see how the display performs from a uniformity perspective. In other words, the leakage of light from the light source. van der Poel CE, Spaapen RM, van de Winkel JG, Leusen JH (2011) Functional characteristics of the high affinity IgG receptor, FcgammaRI. J Immunol 186:2699–2704. https://doi.org/10.4049/jimmunol.1003526 Garon EB, Rizvi NA, Hui R et al (2015) Pembrolizumab for the treatment of non-small-cell lung cancer. N Engl J Med 372:2018–2028. https://doi.org/10.1056/NEJMoa1501824 Tislelizumab is an antiprogrammed cell death protein 1 (PD‐1) antibody with antitumor activity and a tolerable safety profile in patients with various advanced or metastatic cancers.
Dahan R, Sega E, Engelhardt J, Selby M, Korman AJ, Ravetch JV (2015) FcgammaRs modulate the anti-tumor activity of antibodies targeting the PD-1/PD-L1 axis. Cancer Cell 28:285–295. https://doi.org/10.1016/j.ccell.2015.08.004 A randomized, controlled, open‐label, global study comparing the efficacy of the anti–PD‐1 antibody tislelizumab (BGB‐A317) versus chemotherapy as second‐line treatment in patients with advanced unresectable/metastatic esophageal squamous cell carcinoma Nishimura H, Honjo T (2001) PD-1: an inhibitory immunoreceptor involved in peripheral tolerance. Trends Immunol 22:265–268 Generation of M2 macrophages was performed according to the protocol described by Leidi et al. [ 15]. Briefly, human PBMCs were co-cultured in 6-well plates or 100-mm culture dish (Corning) in complete RPMI1640 media supplemented with 30 ng/ml human M-CSF (R&D systems) for 4 days. Adherent cells were retained by gently washing off non- and loose-adherent cells, with half of media replaced, and culture for 2–3 more days. For M2 polarization, 10 ng/ml IL-10 (Peprotech) was added during the last 48 h of culture. ADCPThe one major advantage of this laptop is its price. Besides that, there is the cooling, which is able to perfectly tame the Core i7-1255U. Indeed, this is not the most pretentious CPU when it comes to heat output, but it is pretty powerful itself. Luo L, Wu X, Zhang T et al (2017) Abstract 5626: Investigation of T cell activation by anti-human PD-1 antibodies nivolumab, pembrolizumab and BGB-A317 using tumor-infiltrating lymphocytes (TILs) from colorectal cancer and colorectal liver metastasis patients. Cancer Res 77:5626. https://doi.org/10.1158/1538-7445.am2017-5626
Great Deal 
New Comment